Affymax

Affymax

closed
Innovative biopharmaceutical solutions addressing unmet medical needs in hematology and oncology. Learn more

Employees
Market cap
AUD4.5m
Enterprise valuation
(AUD792k) (Public information from Sep 2024)
Palo Alto California (HQ)
Authorizing premium user...